{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"pt-141-sciatica","title":"PT-141 for Sciatica: Evidence-Graded Review of Repair Pathways","body":"## What's breaking down if you have Sciatica\n\nSciatica involves pain radiating along the sciatic nerve, often due to compression from disc herniation, spinal stenosis, or inflammation. The nerve signals ongoing damage or irritation. Suppressing those signals does not address the underlying compression or tissue breakdown. Repair pathways must outpace ongoing degeneration for symptoms to resolve long-term.\n\n## Why PT-141 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n3. This article centers **PT-141**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\n\nPT-141 (bremelanotide) acts on melanocortin receptors in the central nervous system. This pathway influences arousal and certain neural signaling. No direct link exists to nerve compression repair in sciatica models.\n\n## Why BPC-157 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\n## Why TB-500 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why ARA-290 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\n## How these fit together\n\nEach compound above targets a different degeneration layer. Together they are a **stack** — not five copies of the same mechanism.\n- **PT-141** → sexual / CNS arousal\n- **BPC-157** → structure / tissue\n- **TB-500** → inflammation clearance / repair-cell migration\n- **ARA-290** → nerve / innervation\n\n*Primary focus of this slug: **PT-141**. Others are in scope because the same condition breaks down on multiple layers.*\n\n## What the evidence actually shows\n\nHuman data on these peptides for sciatica is absent. PT-141 has human trials only for sexual dysfunction. BPC-157 has one small human knee injection study showing pain relief but no sciatica or disc data. TB-500 has no human trials for this use. ARA-290 has Phase II human trials in small fiber neuropathy showing reduced pain and some nerve fiber density increases via corneal confocal microscopy.\n\nPreclinical data includes rat sciatic nerve transection models where BPC-157 improved functional recovery and myelination. [TB-500 (thymosin beta-4)](/a/tb-500) showed benefits in diabetic sciatic nerve models for neurovascular function. ARA-290 reduced allodynia in spared nerve injury rodent models.\n\nAnecdotal reports on forums mention BPC-157 and TB-500 stacks for back pain and sciatica relief, but these lack controls or verification.\n\n## What scientists say\n\nResearchers note BPC-157 accelerates axonal regeneration in rat sciatic nerve studies (source from pubmed.ncbi.nlm.nih.gov/19903499). ARA-290 activates innate repair receptors to shift inflammation toward healing in neuropathy models (pmc.ncbi.nlm.nih.gov/articles/PMC5741312/). No peer-reviewed statements link PT-141 to sciatica repair. All note the need for human trials beyond current limited datasets.\n\n## What people say on Reddit\n\nUsers in r/bpc_157 report immediate pain relief and improved walking after BPC-157 for herniated discs with sciatica. One described driving longer distances without discomfort after starting injections. Another combined BPC-157 with TB-500 and noted reduced inflammation and better mobility. These remain individual experiences without medical confirmation.\n\n## What people say on X\n\nPosts on X about these peptides for back or nerve issues are sparse and mostly promotional or general healing claims. No verified high-engagement threads detail sciatica resolution with PT-141 or the stack.\n\n## What we do not know\n\nNo randomized controlled human trials exist for any of these peptides in sciatica. Long-term effects on disc height, nerve compression, or recurrence rates remain unstudied. Interactions with standard care like physical therapy or anti-inflammatories are unknown. PT-141's CNS effects have not been tested in nerve compression contexts.\n\n## Safety and limits\n\nPT-141 is FDA-approved for hypoactive sexual desire disorder with known side effects including nausea and flushing. The others are research compounds with no approved indications for sciatica. Human safety data is limited for repeated use in back conditions. Evidence grades remain preclinical or anecdotal for the condition described.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-sciatica/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"PT-141 has human trials only for sexual dysfunction, with no direct evidence for sciatica or nerve compression repair.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of relevant human data for primary peptide.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"BPC-157 improved functional recovery and myelination in rat sciatic nerve transection models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Direct preclinical support for nerve repair layer.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"ARA-290 showed reduced neuropathic pain and increased corneal nerve fiber density in Phase II human trials for small fiber neuropathy.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Strongest human evidence among scoped peptides for nerve layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report pain relief and mobility gains with BPC-157 for herniated discs causing sciatica.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Captures community experience tier.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder","quote":"The efficacy and safety of bremelanotide, taken as needed over 24 weeks, demonstrated statistically significant and clinically meaningful improvements in low sexual desire.","summary":"Human trial data limited to sexual function indications.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:09:01.376Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"058dc577898acac23cf0a243a884eed0aac03f72d30c033ba4ee92cf21b2a554"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19903499/","title":"Peptide therapy with pentadecapeptide BPC 157 in rats with transected sciatic nerve","quote":"BPC 157 markedly improved rat sciatic nerve healing.","summary":"Rat study showing improved nerve healing metrics.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:09:01.376Z","link_status":"ok","quote_status":"verified","prev":"058dc577898acac23cf0a243a884eed0aac03f72d30c033ba4ee92cf21b2a554","hash":"8b42db1010bb8a2f1627ea6f8b95e3d3f0cf06d5a4c370eb2aba21bc12193ba8"},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"These experimental and clinical studies show that ARA290 effectively reprograms a proinflammatory, tissue-damaging milieu into one of healing and tissue repair.","summary":"Human and animal data on neuropathic pain relief.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:09:01.376Z","link_status":"ok","quote_status":"verified","prev":"8b42db1010bb8a2f1627ea6f8b95e3d3f0cf06d5a4c370eb2aba21bc12193ba8","hash":"b11b7a77e2c9301d77e35d52083f33664c0cfb6d2aa42fc4ae5b232198799dca"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/bpc_157/comments/1foo6q0/bpc_157_to_aid_herniated_discs/","title":"BPC 157 to aid herniated discs?","quote":"I have terrible arthritis in my back and sciatica pain... I have been doing the BPC 157 and TB 500 cycle... great success with it.","summary":"User anecdotes of symptom improvement.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:09:01.376Z","link_status":"ok","quote_status":"unverified","prev":"b11b7a77e2c9301d77e35d52083f33664c0cfb6d2aa42fc4ae5b232198799dca","hash":"e6356372998611547c0cbae27e71ee76b4b48164db8766430b46f4b942f20c58"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":2,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:09:01.966Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Sciatica: Evidence-Graded Review of Repair Pathways","register":"source_ledger","body":"## What's breaking down if you have Sciatica\n\nSciatica involves pain radiating along the sciatic nerve, often due to compression from disc herniation, spinal stenosis, or inflammation. The nerve signals ongoing damage or irritation. Suppressing those signals does not address the underlying compression or tissue breakdown. Repair pathways must outpace ongoing degeneration for symptoms to resolve long-term.\n\n## Why PT-141 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n3. This article centers **PT-141**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\n\nPT-141 (bremelanotide) acts on melanocortin receptors in the central nervous system. This pathway influences arousal and certain neural signaling. No direct link exists to nerve compression repair in sciatica models.\n\n## Why BPC-157 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\n## Why TB-500 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why ARA-290 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\n## How these fit together\n\nEach compound above targets a different degeneration layer. Together they are a **stack** — not five copies of the same mechanism.\n- **PT-141** → sexual / CNS arousal\n- **BPC-157** → structure / tissue\n- **TB-500** → inflammation clearance / repair-cell migration\n- **ARA-290** → nerve / innervation\n\n*Primary focus of this slug: **PT-141**. Others are in scope because the same condition breaks down on multiple layers.*\n\n## What the evidence actually shows\n\nHuman data on these peptides for sciatica is absent. PT-141 has human trials only for sexual dysfunction. BPC-157 has one small human knee injection study showing pain relief but no sciatica or disc data. TB-500 has no human trials for this use. ARA-290 has Phase II human trials in small fiber neuropathy showing reduced pain and some nerve fiber density increases via corneal confocal microscopy.\n\nPreclinical data includes rat sciatic nerve transection models where BPC-157 improved functional recovery and myelination. TB-500 (thymosin beta-4) showed benefits in diabetic sciatic nerve models for neurovascular function. ARA-290 reduced allodynia in spared nerve injury rodent models.\n\nAnecdotal reports on forums mention BPC-157 and TB-500 stacks for back pain and sciatica relief, but these lack controls or verification.\n\n## What scientists say\n\nResearchers note BPC-157 accelerates axonal regeneration in rat sciatic nerve studies (source from pubmed.ncbi.nlm.nih.gov/19903499). ARA-290 activates innate repair receptors to shift inflammation toward healing in neuropathy models (pmc.ncbi.nlm.nih.gov/articles/PMC5741312/). No peer-reviewed statements link PT-141 to sciatica repair. All note the need for human trials beyond current limited datasets.\n\n## What people say on Reddit\n\nUsers in r/bpc_157 report immediate pain relief and improved walking after BPC-157 for herniated discs with sciatica. One described driving longer distances without discomfort after starting injections. Another combined BPC-157 with TB-500 and noted reduced inflammation and better mobility. These remain individual experiences without medical confirmation.\n\n## What people say on X\n\nPosts on X about these peptides for back or nerve issues are sparse and mostly promotional or general healing claims. No verified high-engagement threads detail sciatica resolution with PT-141 or the stack.\n\n## What we do not know\n\nNo randomized controlled human trials exist for any of these peptides in sciatica. Long-term effects on disc height, nerve compression, or recurrence rates remain unstudied. Interactions with standard care like physical therapy or anti-inflammatories are unknown. PT-141's CNS effects have not been tested in nerve compression contexts.\n\n## Safety and limits\n\nPT-141 is FDA-approved for hypoactive sexual desire disorder with known side effects including nausea and flushing. The others are research compounds with no approved indications for sciatica. Human safety data is limited for repeated use in back conditions. Evidence grades remain preclinical or anecdotal for the condition described.","claims":[{"id":"c1","text":"PT-141 has human trials only for sexual dysfunction, with no direct evidence for sciatica or nerve compression repair.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of relevant human data for primary peptide.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"BPC-157 improved functional recovery and myelination in rat sciatic nerve transection models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Direct preclinical support for nerve repair layer.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"ARA-290 showed reduced neuropathic pain and increased corneal nerve fiber density in Phase II human trials for small fiber neuropathy.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Strongest human evidence among scoped peptides for nerve layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report pain relief and mobility gains with BPC-157 for herniated discs causing sciatica.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Captures community experience tier.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder","quote":"The efficacy and safety of bremelanotide, taken as needed over 24 weeks, demonstrated statistically significant and clinically meaningful improvements in low sexual desire.","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19903499/","title":"Peptide therapy with pentadecapeptide BPC 157 in rats with transected sciatic nerve","quote":"BPC 157 markedly improved rat sciatic nerve healing.","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"These experimental and clinical studies show that ARA290 effectively reprograms a proinflammatory, tissue-damaging milieu into one of healing and tissue repair.","link_status":"ok","quote_status":"verified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/bpc_157/comments/1foo6q0/bpc_157_to_aid_herniated_discs/","title":"BPC 157 to aid herniated discs?","quote":"I have terrible arthritis in my back and sciatica pain... I have been doing the BPC 157 and TB 500 cycle... great success with it.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":16071,"tokens_out":3043,"cost":0.02769625,"prev_hash":"genesis","hash":"880c9e8f50fa27d1862db2e63efe2a5d22816b53b155fa68478f2564a1ad5e23"}],"provenance":[{"ts":"2026-06-30T01:09:01.966Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Sciatica\nSlug: pt-141-sciatica\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"multi_stack\",\"condition\":\"Sciatica\",\"condition_key\":\"sciatica\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"},{\"id\":\"bpc-157\",\"name\":\"BPC-157\"},{\"id\":\"tb-500\",\"name\":\"TB-500\"},{\"id\":\"ara-290\",\"name\":\"ARA-290\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Sciatica\",\"degenerative_why\":[\"Sciatica is nerve pain along the sciatic nerve — often from disc herniation or stenosis compressing a root.\",\"The nerve is signaling damage/compression; suppressing pain does not uncompress the nerve.\"],\"degenerative_layers\":[],\"note\":null},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You have **Sciatica** — breakdown is outpacing repair.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\",\"This article centers **PT-141**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\"],\"prose\":\"1. You have **Sciatica** — breakdown is outpacing repair.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n3. This article centers **PT-141**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\"},{\"peptide\":\"bpc-157\",\"name\":\"BPC-157\",\"","response":"{\n  \"slug\": \"pt-141-sciatica\",\n  \"title\": \"PT-141 for Sciatica: Evidence-Graded Review of Repair Pathways\",\n  \"body\": \"## What's breaking down if you have Sciatica\\n\\nSciatica involves pain radiating along the sciatic nerve, often due to compression from disc herniation, spinal stenosis, or inflammation. The nerve signals ongoing damage or irritation. Suppressing those signals does not address the underlying compression or tissue breakdown. Repair pathways must outpace ongoing degeneration for symptoms to resolve long-term.\\n\\n## Why PT-141 might help you\\n\\n1. You have **Sciatica** — breakdown is outpacing repair.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n3. This article centers **PT-141**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\\n\\nPT-141 (bremelanotide) acts on melanocortin receptors in the central nervous system. This pathway influences arousal and certain neural signaling. No direct link exists to nerve compression repair in sciatica models.\\n\\n## Why BPC-157 might help you\\n\\n1. You have **Sciatica** — breakdown is outpacing repair.\\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\\n\\n## Why TB-500 might help you\\n\\n1. You have **Sciatica** — breakdown is outpacing repair.\\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n4. **Therefore for you:** If that layer is part o","tokens_in":16071,"tokens_out":3043,"cost":0,"prev":"genesis","hash":"9827c736962be8cd835febeddd9b54b769a2a6102812f435ddc83784e9ac6707"},{"ts":"2026-07-17T02:41:09.913Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-sciatica","response":"29 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9827c736962be8cd835febeddd9b54b769a2a6102812f435ddc83784e9ac6707","hash":"293c536ff60685b85fcfa989a5cadb844c9c5805b4d627f58b83b363659f10fd"},{"ts":"2026-08-06T09:15:52.270Z","model":"unknown","action":"edit","why":"this article pointed at nothing; the reference was already written in the prose, so linking it invents no relationship","prompt":"","input":"","response":"","tokens_in":0,"tokens_out":0,"cost":0,"prev":"293c536ff60685b85fcfa989a5cadb844c9c5805b4d627f58b83b363659f10fd","hash":"17e9fc83afb7aa83e5cc88b33f8bf735f74decbc756fb6f6012f3956703c0cf4"}],"energy":{"passes":3,"tokens_in":16071,"tokens_out":3043,"tokens_total":19114,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1,"unknown":1},"head":"17e9fc83afb7aa83e5cc88b33f8bf735f74decbc756fb6f6012f3956703c0cf4"},"posted_at":"2026-06-29T21:32:55.355Z","created_at":"2026-06-29T21:32:55.355Z","updated_at":"2026-08-06T09:15:52.270Z","machine":{"shape":"article.machine/v1","slug":"pt-141-sciatica","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-sciatica","json":"https://miscsubjects.com/api/articles/pt-141-sciatica","bundle":"https://miscsubjects.com/api/articles/pt-141-sciatica/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":2,"objections_url":"https://miscsubjects.com/api/articles/pt-141-sciatica/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-sciatica","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-sciatica\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-sciatica\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-sciatica/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-sciatica\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-sciatica | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-sciatica","json":"/api/articles/pt-141-sciatica","markdown":"/api/articles/pt-141-sciatica/bundle?format=markdown","skill":"/api/articles/pt-141-sciatica/skill","topology":"/api/articles/pt-141-sciatica/topology","versions":"/api/articles/pt-141-sciatica/revisions","invocations":"/api/articles/pt-141-sciatica/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-sciatica","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"9f3ae37746837a481dd1a9851208d38a1685cdbc882bd0d8b6e5dbc40be57cfd","object":{"object_type":"article-object","identity":{"id":"article:pt-141-sciatica","slug":"pt-141-sciatica","title":"PT-141 for Sciatica: Evidence-Graded Review of Repair Pathways"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/pt-141-sciatica","role":"explain","audience":"human"},"skill":{"route":"/api/articles/pt-141-sciatica/skill","role":"direct behavior","audience":"model","content":"---\nname: pt-141-sciatica\ndescription: Apply the PT-141 for Sciatica: Evidence-Graded Review of Repair Pathways article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# PT-141 for Sciatica: Evidence-Graded Review of Repair Pathways\n\nThis Skill is the behavioral expression of [the canonical article](/a/pt-141-sciatica). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/pt-141-sciatica.\n- Read claims and relationships at /api/articles/pt-141-sciatica/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Sciatica Sciatica involves pain radiating along the sciatic nerve, often due to compression from disc herniation, spinal stenosis, or inflammation. The nerve signals ongoing damage or irritation. Suppressing\n\n## Representations\n\n- Human: /a/pt-141-sciatica\n- JSON: /api/articles/pt-141-sciatica\n- Relationships: /api/articles/pt-141-sciatica/topology\n- History: /api/articles/pt-141-sciatica/revisions\n"},"json":{"route":"/api/articles/pt-141-sciatica","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/pt-141-sciatica/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","pt","141","sciatica"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/pt-141-sciatica/invocations?status=success","failure_events":"/api/articles/pt-141-sciatica/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"pt-141-sciatica","title":"PT-141 for Sciatica: Evidence-Graded Review of Repair Pathways","body":"## What's breaking down if you have Sciatica\n\nSciatica involves pain radiating along the sciatic nerve, often due to compression from disc herniation, spinal stenosis, or inflammation. The nerve signals ongoing damage or irritation. Suppressing those signals does not address the underlying compression or tissue breakdown. Repair pathways must outpace ongoing degeneration for symptoms to resolve long-term.\n\n## Why PT-141 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n3. This article centers **PT-141**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\n\nPT-141 (bremelanotide) acts on melanocortin receptors in the central nervous system. This pathway influences arousal and certain neural signaling. No direct link exists to nerve compression repair in sciatica models.\n\n## Why BPC-157 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\n## Why TB-500 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why ARA-290 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\n## How these fit together\n\nEach compound above targets a different degeneration layer. Together they are a **stack** — not five copies of the same mechanism.\n- **PT-141** → sexual / CNS arousal\n- **BPC-157** → structure / tissue\n- **TB-500** → inflammation clearance / repair-cell migration\n- **ARA-290** → nerve / innervation\n\n*Primary focus of this slug: **PT-141**. Others are in scope because the same condition breaks down on multiple layers.*\n\n## What the evidence actually shows\n\nHuman data on these peptides for sciatica is absent. PT-141 has human trials only for sexual dysfunction. BPC-157 has one small human knee injection study showing pain relief but no sciatica or disc data. TB-500 has no human trials for this use. ARA-290 has Phase II human trials in small fiber neuropathy showing reduced pain and some nerve fiber density increases via corneal confocal microscopy.\n\nPreclinical data includes rat sciatic nerve transection models where BPC-157 improved functional recovery and myelination. [TB-500 (thymosin beta-4)](/a/tb-500) showed benefits in diabetic sciatic nerve models for neurovascular function. ARA-290 reduced allodynia in spared nerve injury rodent models.\n\nAnecdotal reports on forums mention BPC-157 and TB-500 stacks for back pain and sciatica relief, but these lack controls or verification.\n\n## What scientists say\n\nResearchers note BPC-157 accelerates axonal regeneration in rat sciatic nerve studies (source from pubmed.ncbi.nlm.nih.gov/19903499). ARA-290 activates innate repair receptors to shift inflammation toward healing in neuropathy models (pmc.ncbi.nlm.nih.gov/articles/PMC5741312/). No peer-reviewed statements link PT-141 to sciatica repair. All note the need for human trials beyond current limited datasets.\n\n## What people say on Reddit\n\nUsers in r/bpc_157 report immediate pain relief and improved walking after BPC-157 for herniated discs with sciatica. One described driving longer distances without discomfort after starting injections. Another combined BPC-157 with TB-500 and noted reduced inflammation and better mobility. These remain individual experiences without medical confirmation.\n\n## What people say on X\n\nPosts on X about these peptides for back or nerve issues are sparse and mostly promotional or general healing claims. No verified high-engagement threads detail sciatica resolution with PT-141 or the stack.\n\n## What we do not know\n\nNo randomized controlled human trials exist for any of these peptides in sciatica. Long-term effects on disc height, nerve compression, or recurrence rates remain unstudied. Interactions with standard care like physical therapy or anti-inflammatories are unknown. PT-141's CNS effects have not been tested in nerve compression contexts.\n\n## Safety and limits\n\nPT-141 is FDA-approved for hypoactive sexual desire disorder with known side effects including nausea and flushing. The others are research compounds with no approved indications for sciatica. Human safety data is limited for repeated use in back conditions. Evidence grades remain preclinical or anecdotal for the condition described.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-sciatica/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"PT-141 has human trials only for sexual dysfunction, with no direct evidence for sciatica or nerve compression repair.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of relevant human data for primary peptide.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"BPC-157 improved functional recovery and myelination in rat sciatic nerve transection models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Direct preclinical support for nerve repair layer.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"ARA-290 showed reduced neuropathic pain and increased corneal nerve fiber density in Phase II human trials for small fiber neuropathy.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Strongest human evidence among scoped peptides for nerve layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report pain relief and mobility gains with BPC-157 for herniated discs causing sciatica.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Captures community experience tier.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder","quote":"The efficacy and safety of bremelanotide, taken as needed over 24 weeks, demonstrated statistically significant and clinically meaningful improvements in low sexual desire.","summary":"Human trial data limited to sexual function indications.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:09:01.376Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"058dc577898acac23cf0a243a884eed0aac03f72d30c033ba4ee92cf21b2a554"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19903499/","title":"Peptide therapy with pentadecapeptide BPC 157 in rats with transected sciatic nerve","quote":"BPC 157 markedly improved rat sciatic nerve healing.","summary":"Rat study showing improved nerve healing metrics.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:09:01.376Z","link_status":"ok","quote_status":"verified","prev":"058dc577898acac23cf0a243a884eed0aac03f72d30c033ba4ee92cf21b2a554","hash":"8b42db1010bb8a2f1627ea6f8b95e3d3f0cf06d5a4c370eb2aba21bc12193ba8"},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"These experimental and clinical studies show that ARA290 effectively reprograms a proinflammatory, tissue-damaging milieu into one of healing and tissue repair.","summary":"Human and animal data on neuropathic pain relief.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:09:01.376Z","link_status":"ok","quote_status":"verified","prev":"8b42db1010bb8a2f1627ea6f8b95e3d3f0cf06d5a4c370eb2aba21bc12193ba8","hash":"b11b7a77e2c9301d77e35d52083f33664c0cfb6d2aa42fc4ae5b232198799dca"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/bpc_157/comments/1foo6q0/bpc_157_to_aid_herniated_discs/","title":"BPC 157 to aid herniated discs?","quote":"I have terrible arthritis in my back and sciatica pain... I have been doing the BPC 157 and TB 500 cycle... great success with it.","summary":"User anecdotes of symptom improvement.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:09:01.376Z","link_status":"ok","quote_status":"unverified","prev":"b11b7a77e2c9301d77e35d52083f33664c0cfb6d2aa42fc4ae5b232198799dca","hash":"e6356372998611547c0cbae27e71ee76b4b48164db8766430b46f4b942f20c58"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":2,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:09:01.966Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Sciatica: Evidence-Graded Review of Repair Pathways","register":"source_ledger","body":"## What's breaking down if you have Sciatica\n\nSciatica involves pain radiating along the sciatic nerve, often due to compression from disc herniation, spinal stenosis, or inflammation. The nerve signals ongoing damage or irritation. Suppressing those signals does not address the underlying compression or tissue breakdown. Repair pathways must outpace ongoing degeneration for symptoms to resolve long-term.\n\n## Why PT-141 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n3. This article centers **PT-141**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\n\nPT-141 (bremelanotide) acts on melanocortin receptors in the central nervous system. This pathway influences arousal and certain neural signaling. No direct link exists to nerve compression repair in sciatica models.\n\n## Why BPC-157 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\n\n## Why TB-500 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\n4. **Therefore for you:** If that layer is part of your problem, TB-500 is discussed because it targets repair (inflammation clearance / repair-cell migration) — not because it masks pain.\n\n## Why ARA-290 might help you\n\n1. You have **Sciatica** — breakdown is outpacing repair.\n2. **What keeps failing:** Nerve compression, small-fiber loss, neuropathic pain signaling without tissue repair.\n3. **What ARA-290 is studied to do:** Studied for nerve repair and small-fiber regeneration in neuropathy models.\n4. **Therefore for you:** If that layer is part of your problem, ARA-290 is discussed because it targets repair (nerve / innervation) — not because it masks pain.\n\n## How these fit together\n\nEach compound above targets a different degeneration layer. Together they are a **stack** — not five copies of the same mechanism.\n- **PT-141** → sexual / CNS arousal\n- **BPC-157** → structure / tissue\n- **TB-500** → inflammation clearance / repair-cell migration\n- **ARA-290** → nerve / innervation\n\n*Primary focus of this slug: **PT-141**. Others are in scope because the same condition breaks down on multiple layers.*\n\n## What the evidence actually shows\n\nHuman data on these peptides for sciatica is absent. PT-141 has human trials only for sexual dysfunction. BPC-157 has one small human knee injection study showing pain relief but no sciatica or disc data. TB-500 has no human trials for this use. ARA-290 has Phase II human trials in small fiber neuropathy showing reduced pain and some nerve fiber density increases via corneal confocal microscopy.\n\nPreclinical data includes rat sciatic nerve transection models where BPC-157 improved functional recovery and myelination. TB-500 (thymosin beta-4) showed benefits in diabetic sciatic nerve models for neurovascular function. ARA-290 reduced allodynia in spared nerve injury rodent models.\n\nAnecdotal reports on forums mention BPC-157 and TB-500 stacks for back pain and sciatica relief, but these lack controls or verification.\n\n## What scientists say\n\nResearchers note BPC-157 accelerates axonal regeneration in rat sciatic nerve studies (source from pubmed.ncbi.nlm.nih.gov/19903499). ARA-290 activates innate repair receptors to shift inflammation toward healing in neuropathy models (pmc.ncbi.nlm.nih.gov/articles/PMC5741312/). No peer-reviewed statements link PT-141 to sciatica repair. All note the need for human trials beyond current limited datasets.\n\n## What people say on Reddit\n\nUsers in r/bpc_157 report immediate pain relief and improved walking after BPC-157 for herniated discs with sciatica. One described driving longer distances without discomfort after starting injections. Another combined BPC-157 with TB-500 and noted reduced inflammation and better mobility. These remain individual experiences without medical confirmation.\n\n## What people say on X\n\nPosts on X about these peptides for back or nerve issues are sparse and mostly promotional or general healing claims. No verified high-engagement threads detail sciatica resolution with PT-141 or the stack.\n\n## What we do not know\n\nNo randomized controlled human trials exist for any of these peptides in sciatica. Long-term effects on disc height, nerve compression, or recurrence rates remain unstudied. Interactions with standard care like physical therapy or anti-inflammatories are unknown. PT-141's CNS effects have not been tested in nerve compression contexts.\n\n## Safety and limits\n\nPT-141 is FDA-approved for hypoactive sexual desire disorder with known side effects including nausea and flushing. The others are research compounds with no approved indications for sciatica. Human safety data is limited for repeated use in back conditions. Evidence grades remain preclinical or anecdotal for the condition described.","claims":[{"id":"c1","text":"PT-141 has human trials only for sexual dysfunction, with no direct evidence for sciatica or nerve compression repair.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes absence of relevant human data for primary peptide.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"BPC-157 improved functional recovery and myelination in rat sciatic nerve transection models.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Direct preclinical support for nerve repair layer.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"ARA-290 showed reduced neuropathic pain and increased corneal nerve fiber density in Phase II human trials for small fiber neuropathy.","section":"What the evidence actually shows","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Strongest human evidence among scoped peptides for nerve layer.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Reddit users report pain relief and mobility gains with BPC-157 for herniated discs causing sciatica.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Captures community experience tier.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:09:01.593Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder","quote":"The efficacy and safety of bremelanotide, taken as needed over 24 weeks, demonstrated statistically significant and clinically meaningful improvements in low sexual desire.","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/19903499/","title":"Peptide therapy with pentadecapeptide BPC 157 in rats with transected sciatic nerve","quote":"BPC 157 markedly improved rat sciatic nerve healing.","link_status":"ok","quote_status":"verified"},{"id":"s3","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5741312/","title":"Targeting the innate repair receptor to treat neuropathy","quote":"These experimental and clinical studies show that ARA290 effectively reprograms a proinflammatory, tissue-damaging milieu into one of healing and tissue repair.","link_status":"ok","quote_status":"verified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/bpc_157/comments/1foo6q0/bpc_157_to_aid_herniated_discs/","title":"BPC 157 to aid herniated discs?","quote":"I have terrible arthritis in my back and sciatica pain... I have been doing the BPC 157 and TB 500 cycle... great success with it.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":16071,"tokens_out":3043,"cost":0.02769625,"prev_hash":"genesis","hash":"880c9e8f50fa27d1862db2e63efe2a5d22816b53b155fa68478f2564a1ad5e23"}],"provenance":[{"ts":"2026-06-30T01:09:01.966Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Sciatica\nSlug: pt-141-sciatica\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"multi_stack\",\"condition\":\"Sciatica\",\"condition_key\":\"sciatica\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"},{\"id\":\"bpc-157\",\"name\":\"BPC-157\"},{\"id\":\"tb-500\",\"name\":\"TB-500\"},{\"id\":\"ara-290\",\"name\":\"ARA-290\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Sciatica\",\"degenerative_why\":[\"Sciatica is nerve pain along the sciatic nerve — often from disc herniation or stenosis compressing a root.\",\"The nerve is signaling damage/compression; suppressing pain does not uncompress the nerve.\"],\"degenerative_layers\":[],\"note\":null},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You have **Sciatica** — breakdown is outpacing repair.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\",\"This article centers **PT-141**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\"],\"prose\":\"1. You have **Sciatica** — breakdown is outpacing repair.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n3. This article centers **PT-141**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\"},{\"peptide\":\"bpc-157\",\"name\":\"BPC-157\",\"","response":"{\n  \"slug\": \"pt-141-sciatica\",\n  \"title\": \"PT-141 for Sciatica: Evidence-Graded Review of Repair Pathways\",\n  \"body\": \"## What's breaking down if you have Sciatica\\n\\nSciatica involves pain radiating along the sciatic nerve, often due to compression from disc herniation, spinal stenosis, or inflammation. The nerve signals ongoing damage or irritation. Suppressing those signals does not address the underlying compression or tissue breakdown. Repair pathways must outpace ongoing degeneration for symptoms to resolve long-term.\\n\\n## Why PT-141 might help you\\n\\n1. You have **Sciatica** — breakdown is outpacing repair.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n3. This article centers **PT-141**; see other sections for bpc-157, tb-500, ara-290 — different layers, same condition.\\n\\nPT-141 (bremelanotide) acts on melanocortin receptors in the central nervous system. This pathway influences arousal and certain neural signaling. No direct link exists to nerve compression repair in sciatica models.\\n\\n## Why BPC-157 might help you\\n\\n1. You have **Sciatica** — breakdown is outpacing repair.\\n2. **What keeps failing:** Poor blood supply at injury, weak collagen organization, slow tissue turnover.\\n3. **What BPC-157 is studied to do:** Studied for growing new blood vessels (angiogenesis) so repair material reaches damaged tissue.\\n4. **Therefore for you:** If that layer is part of your problem, BPC-157 is discussed because it targets repair (structure / tissue) — not because it masks pain.\\n\\n## Why TB-500 might help you\\n\\n1. You have **Sciatica** — breakdown is outpacing repair.\\n2. **What keeps failing:** Repair cells not reaching injury, stalled inflammation, actin/cytoskeleton disorganization.\\n3. **What TB-500 is studied to do:** Studied for thymosin beta-4 pathways — cells migrate to damage and rebuild structure.\\n4. **Therefore for you:** If that layer is part o","tokens_in":16071,"tokens_out":3043,"cost":0,"prev":"genesis","hash":"9827c736962be8cd835febeddd9b54b769a2a6102812f435ddc83784e9ac6707"},{"ts":"2026-07-17T02:41:09.913Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-sciatica","response":"29 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"9827c736962be8cd835febeddd9b54b769a2a6102812f435ddc83784e9ac6707","hash":"293c536ff60685b85fcfa989a5cadb844c9c5805b4d627f58b83b363659f10fd"},{"ts":"2026-08-06T09:15:52.270Z","model":"unknown","action":"edit","why":"this article pointed at nothing; the reference was already written in the prose, so linking it invents no relationship","prompt":"","input":"","response":"","tokens_in":0,"tokens_out":0,"cost":0,"prev":"293c536ff60685b85fcfa989a5cadb844c9c5805b4d627f58b83b363659f10fd","hash":"17e9fc83afb7aa83e5cc88b33f8bf735f74decbc756fb6f6012f3956703c0cf4"}],"energy":{"passes":3,"tokens_in":16071,"tokens_out":3043,"tokens_total":19114,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1,"unknown":1},"head":"17e9fc83afb7aa83e5cc88b33f8bf735f74decbc756fb6f6012f3956703c0cf4"},"posted_at":"2026-06-29T21:32:55.355Z","created_at":"2026-06-29T21:32:55.355Z","updated_at":"2026-08-06T09:15:52.270Z","machine":{"shape":"article.machine/v1","slug":"pt-141-sciatica","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-sciatica","json":"https://miscsubjects.com/api/articles/pt-141-sciatica","bundle":"https://miscsubjects.com/api/articles/pt-141-sciatica/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":2,"objections_url":"https://miscsubjects.com/api/articles/pt-141-sciatica/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-sciatica","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-sciatica\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-sciatica\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-sciatica/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-sciatica\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-sciatica | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-sciatica","json":"/api/articles/pt-141-sciatica","markdown":"/api/articles/pt-141-sciatica/bundle?format=markdown","skill":"/api/articles/pt-141-sciatica/skill","topology":"/api/articles/pt-141-sciatica/topology","versions":"/api/articles/pt-141-sciatica/revisions","invocations":"/api/articles/pt-141-sciatica/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-sciatica","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"9f3ae37746837a481dd1a9851208d38a1685cdbc882bd0d8b6e5dbc40be57cfd"}}}